The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
One-year follow-up of health-related quality of life in the Swedish PREDIX HER 2 trial, evaluating docetaxel, trastuzumab sc, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2 positive breast cancer.
 
Yvonne Brandberg
No Relationships to Disclose
 
Theodoros Foukakis
Honoraria - UpToDate
Consulting or Advisory Role - Pfizer (Inst)
Research Funding - Pfizer (Inst)
 
Anne Andersson
No Relationships to Disclose
 
Judith Bjohle
No Relationships to Disclose
 
Ana Bosch
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Lena Carlsson
No Relationships to Disclose
 
Zakaria Einbeigi
No Relationships to Disclose
 
Hanna Fredholm
No Relationships to Disclose
 
Erika Isaksson-Friman
Research Funding - Novartis (Inst)
 
Mats Hellstrom
No Relationships to Disclose
 
Hemming Johansson
No Relationships to Disclose
 
Tobias Lekberg
No Relationships to Disclose
 
Henrik Lindman
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; Novartis
Consulting or Advisory Role - Daiichi Sankyo; Lilly; MSD Oncology; Oasmia Pharmaceutical AB
Research Funding - Roche (Inst)
 
Jonas C. S. Bergh
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Other Relationship - Asklepios BioPharmaceutical
 
Thomas Hatschek
Consulting or Advisory Role - Pfizer; Pierre Fabre; Roche
Research Funding - Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche